Q1 2024 · 13F-HR
Ally Bridge Group (NY) LLCholdings as filed
Filed 2024-05-15 · accession 0000950123-24-005227
$179.9M
Reported value
22
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $15.3M | 8.49% | 160,950 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $14.4M | 8.01% | 336,486 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $14.1M | 7.82% | 320,378 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $13.3M | 7.40% | 309,369 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $11.9M | 6.59% | 736,738 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $11.5M | 6.41% | 255,928 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $9.7M | 5.41% | 159,486 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $9.4M | 5.23% | 1,001,452 | Common | SOLE |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $9.2M | 5.14% | 547,036 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $9.1M | 5.06% | 2,760,497 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $8.5M | 4.73% | 289,943 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $7.8M | 4.33% | 365,044 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $6.8M | 3.77% | 250,000 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $6.5M | 3.62% | 216,968 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $6.3M | 3.52% | 559,035 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $6.2M | 3.47% | 1,003,741 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $5.8M | 3.25% | 270,559 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $3.8M | 2.10% | 420,000 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $3.6M | 2.00% | 801,437 | Common | SOLE |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $3.6M | 1.98% | 394,773 | Common | SOLE |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $2.0M | 1.13% | 1,059,582 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $1.0M | 0.56% | 725,951 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.